Your browser doesn't support javascript.
loading
Effect of a smartphone-based intervention on secondary prevention medication prescriptions after coronary artery bypass graft surgery: The MISSION-1 randomized controlled trial.
Qu, Jianyu; Du, Junzhe; Rao, Chenfei; Chen, Sipeng; Gu, Dachuan; Li, Jing; Zhang, Heng; Zhao, Yan; Hu, Shengshou; Zheng, Zhe.
Afiliación
  • Qu J; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Cardiovascular Surgery, Fuwai H
  • Du J; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Cardiovascular Surgery, Fuwai H
  • Rao C; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Cardiovascular Surgery, Fuwai H
  • Chen S; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Information Center, Fuwai Hospital, National
  • Gu D; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Cardiovascular Surgery, Fuwai H
  • Li J; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Zhang H; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Cardiovascular Surgery, Fuwai H
  • Zhao Y; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Hu S; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Cardiovascular Surgery, Fuwai H
  • Zheng Z; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Cardiovascular Surgery, Fuwai H
Am Heart J ; 237: 79-89, 2021 07.
Article en En | MEDLINE | ID: mdl-33689732

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Prescripciones de Medicamentos / Inhibidores de la Enzima Convertidora de Angiotensina / Puente de Arteria Coronaria / Antagonistas Adrenérgicos beta / Prevención Secundaria / Antagonistas de Receptores de Angiotensina Tipo de estudio: Clinical_trials / Guideline Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Prescripciones de Medicamentos / Inhibidores de la Enzima Convertidora de Angiotensina / Puente de Arteria Coronaria / Antagonistas Adrenérgicos beta / Prevención Secundaria / Antagonistas de Receptores de Angiotensina Tipo de estudio: Clinical_trials / Guideline Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Año: 2021 Tipo del documento: Article